摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-methyl-2,3,6,7,8,9-hexahydro-1H-imidazo[1,2-b]isoquinolin-5-one | 66066-49-7

中文名称
——
中文别名
——
英文名称
1-methyl-2,3,6,7,8,9-hexahydro-1H-imidazo[1,2-b]isoquinolin-5-one
英文别名
1-methyl-5-oxo-1,2,3,5,6,7,8,9-octahydroimidazo[1,2-b]isoquinoline;6,7-Tetramethylen-1-methyl-5-oxo-2,3-dihydro-1H,5H-imidazo<1,2-a>pyridin;1-Methyl-2,3,6,7,8,9-hexahydroimidazo[1,2-b]isoquinolin-5-one
1-methyl-2,3,6,7,8,9-hexahydro-1<i>H</i>-imidazo[1,2-<i>b</i>]isoquinolin-5-one化学式
CAS
66066-49-7
化学式
C12H16N2O
mdl
——
分子量
204.272
InChiKey
HTJQMLKHZLDTJW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    111-112 °C(Solv: cyclohexane (110-82-7))
  • 沸点:
    462.7±15.0 °C(Predicted)
  • 密度:
    1.22±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    23.6
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    2-cyanomethylene-cyclohexanecarboxylic acid ethyl ester 、 N-甲基乙二胺 以13%的产率得到
    参考文献:
    名称:
    KUBO KAZUO; ITO NORIKI; ISOMURA YASUO; SOZU ISAO; HOMMA HIROSHIGE; MURAKA+, YAKUGAKU DZASSI, JAKUGAKU ZASSNI, J. PHARM. SOS. JAR., 1979, 99, NO 9, 88+
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Nitrogen-containing heterocyclic ring derivatives and analgesic and
    申请人:Yamanouchi Pharmaceutical Co., Ltd.
    公开号:US04288438A1
    公开(公告)日:1981-09-08
    Novel nitrogen-containing heterocyclic compounds shown by the formula ##STR1## wherein one of R.sub.1 and R.sub.2 represents a lower alkyl group, a phenyl group, a halophenyl group, or a lower alkoxyphenyl group and the other of them represents a hydrogen atom, a lower alkyl group, or a phenyl lower alkyl group; said R.sub.1 and R.sub.2 may combine with each other to form a trimethylene group or a tetramethylene group; R.sub.3 represents a hydrogen atom, a lower alkyl group, a phenyl group, or a phenyl lower alkyl group; X represents an oxygen atom, a sulfur atom, an imino group, or a group shown by ##STR2## (wherein m represents 1 or 2 and R.sub.4 represents a lower alkyl group, a hydroxy lower alkyl group, a cycloalkyl group or a phenyl lower alkyl group); and Y represents an ethylene group which may be substituted by lower alkyl group, a trimethylene group, a tetramethylene group, a vinylene group which may be substituted by a lower alkyl group, or ##STR3## (wherein R.sub.5 represents a hydrogen atom, a lower alkyl group, a trifluoromethyl group, or a phenyl group); said X is the group shown by ##STR4## when one of said R.sub.1 and R.sub.2 is a lower alkyl group and the other is a hydrogen atom, and said Y is an ethylene group, and the pharmacologically acceptable non-toxic salts thereof. The compounds described above are strong analgesic anti-inflammatory agents.
    根据下面的公式所示的新型含氮杂环化合物,其中R.sub.1和R.sub.2中的一个代表低烷基基团、苯基、卤苯基或低烷氧基苯基,另一个代表氢原子、低烷基基团或苯低烷基基团;所述的R.sub.1和R.sub.2可以结合在一起形成三亚甲基基团或四亚甲基基团;R.sub.3代表氢原子、低烷基基团、苯基或苯低烷基基团;X代表氧原子、硫原子、亚胺基团或由##STR2##所示的基团(其中m代表1或2,R.sub.4代表低烷基基团、羟基低烷基基团、环烷基团或苯基低烷基基团);Y代表乙烯基,可以被低烷基基团、三亚甲基基团、四亚甲基基团、乙烯基取代,或者##STR3##(其中R.sub.5代表氢原子、低烷基基团、三氟甲基基团或苯基);当R.sub.1和R.sub.2中的一个是低烷基基团,另一个是氢原子时,X是由##STR4##所示的基团,Y是乙烯基,以及其药理学上可接受的无毒盐。上述描述的化合物是强效的镇痛抗炎药物。
  • Novel fused derivatives of 2-pyridones
    申请人:Yamanouchi Pharmaceutical Co., Ltd.
    公开号:US04186200A1
    公开(公告)日:1980-01-29
    Novel nitrogen-containing heterocyclic compounds shown by the formula ##STR1## wherein one of R.sub.1 and R.sub.2 represents a lower alkyl group, a phenyl group, a halophenyl group, or a lower alkoxyphenyl group and the other of them represents a hydrogen atom, a lower alkyl group, or a phenyl lower alkyl group; said R.sub.1 and R.sub.2 may combine with each other to form a trimethylene group or a tetramethylene group; R.sub.3 represents a hydrogen atom, a lower alkyl group, a phenyl group, or a phenyl lower alkyl group; X represents an oxygen atom, a sulfur atom, an imino group, or a group shown by ##STR2## wherein m represents 1 or 2 and R.sub.4 represents a lower alkyl group, a hydroxy lower alkyl group, a cycloalkyl group or a phenyl lower alkyl group; and Y represents an ethylene group which may be substituted by lower alkyl group, a trimethylene group, a tetramethylene group, a vinylene group which may be substituted by a lower alkyl group, or ##STR3## wherein R.sub.5 represents a hydrogen atom, a lower alkyl group, a trifluoromethyl group, or a phenyl group; said X is the group shown by ##STR4## when one of said R.sub.1 and R.sub.2 is a lower alkyl group and the other is a hydrogen atom, and said Y is an ethylene group, and the pharmacologically acceptable non-toxic salts thereof. The compounds described above are strong analgesic anti-inflammatory agents.
    根据以下公式所示的新颖含氮杂环化合物:其中R.sub.1和R.sub.2中的一个代表较低的烷基基团、苯基、卤苯基团或较低的烷氧基苯基团,另一个代表氢原子、较低的烷基基团或苯较低的烷基基团;所述的R.sub.1和R.sub.2可以结合在一起形成三亚甲基基团或四亚甲基基团;R.sub.3代表氢原子、较低的烷基基团、苯基或苯较低的烷基基团;X代表氧原子、硫原子、亚胺基团或由##STR2##所示的基团,其中m代表1或2,R.sub.4代表较低的烷基基团、羟基较低的烷基基团、环烷基基团或苯较低的烷基基团;Y代表一个乙烯基,可以被较低的烷基基团取代,一个三亚甲基基团,一个四亚甲基基团,一个乙烯基可以被较低的烷基基团取代,或者##STR3##其中R.sub.5代表氢原子、较低的烷基基团、三氟甲基基团或苯基;当R.sub.1和R.sub.2中的一个是较低的烷基基团,另一个是氢原子时,X是由##STR4##所示的基团,Y是一个乙烯基,以及其药理学上可接受的无毒盐。上述化合物是强镇痛抗炎剂。
  • US4186200A
    申请人:——
    公开号:US4186200A
    公开(公告)日:1980-01-29
  • US4251533A
    申请人:——
    公开号:US4251533A
    公开(公告)日:1981-02-17
  • US4284778A
    申请人:——
    公开号:US4284778A
    公开(公告)日:1981-08-18
查看更多